Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Fuzhou
Clinical trial register · China

Clinical Trials in Fuzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 23 Guangzhou 21 Shanghai 13 Hangzhou 11 Wuhan 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca67 Fujian Medical University Union Hospital46 First Affiliated Hospital of Fujian Medical University44 Merck Sharp & Dohme LLC41 Fujian Cancer Hospital35 Fujian Medical University33 BeOne Medicines24 Pfizer21 Hoffmann-La Roche19 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.19 Janssen Research & Development, LLC18 Bristol-Myers Squibb18 Fujian Provincial Hospital17 Sun Yat-sen University16 Amgen14 Beijing InnoCare Pharma Tech Co., Ltd.13 Sanofi12 Daiichi Sankyo11 Fudan University11 Eli Lilly and Company10 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.10 AbbVie10 Novartis Pharmaceuticals10 MediLink Therapeutics (Suzhou) Co., Ltd.8 Second Affiliated Hospital, Zhejiang University, School of Medicine8 Boehringer Ingelheim7 Abbisko Therapeutics Co, Ltd7 BeiGene7 Nanjing Leads Biolabs Co.,Ltd7 RemeGen Co., Ltd.6 Shanghai Pharmaceuticals Holding Co., Ltd6 Gilead Sciences6 Huashan Hospital6 Takeda6 Nanfang Hospital, Southern Medical University6 Shanghai Henlius Biotech6 Innovent Biologics (Suzhou) Co. Ltd.6 Jiangsu Simcere Pharmaceutical Co., Ltd.5 Shanghai Jiao Tong University School of Medicine5 BioNTech SE5 First Hospital of China Medical University5 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.5 Fuzhou General Hospital5 Hutchmed5 Akeso5 DualityBio Inc.5 Shanghai Junshi Bioscience Co., Ltd.5 Wan-Jin Chen5 Institute of Hematology & Blood Diseases Hospital, China4 Peking University First Hospital4 Bayer4 Sichuan Baili Pharmaceutical Co., Ltd.4 Lepu Biopharma Co., Ltd.4 Genmab4 Shanghai Zhongshan Hospital4 argenx4 Dizal Pharmaceuticals4 First Affiliated Hospital of Zhejiang University4 Ning Wang, MD., PhD.4 Hansoh BioMedical R&D Company4 Biogen4 Ausper Biopharma Co., Ltd.4 Eye & ENT Hospital of Fudan University4 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.4 Xuanwu Hospital, Beijing3 Astellas Pharma Global Development, Inc.3 InxMed (Shanghai) Co., Ltd.3 Capital Medical University3 UCB Biopharma SRL3 Shanghai Jiaolian Drug Research and Development Co., Ltd3 Mirati Therapeutics Inc.3 Summit Therapeutics3 CStone Pharmaceuticals3 Cancer Institute and Hospital, Chinese Academy of Medical Sciences3 Zai Lab (Shanghai) Co., Ltd.3 Chinese Academy of Sciences3 Haisco Pharmaceutical Group Co., Ltd.3 Loxo Oncology, Inc.3 Multitude Therapeutics Inc.3 Antengene Biologics Limited3 Jiangsu Alphamab Biopharmaceuticals Co., Ltd3 3D Medicines (Sichuan) Co., Ltd.3 Stomatological Hospital Affiliated with Fujian Medical University3 Allist Pharmaceuticals, Inc.3 Jiangsu HengRui Medicine Co., Ltd.3 Alexion Pharmaceuticals, Inc.3 TransThera Sciences (Nanjing), Inc.3 Klus Pharma Inc.2 Wayshine Biopharm, Inc.2 Xiamen Amoytop Biotech Co., Ltd.2 Bin Cai2 Ting YANG2 Second Affiliated Hospital of Nanchang University2 Guang'anmen Hospital of China Academy of Chinese Medical Sciences2 Suzhou Suncadia Biopharmaceuticals Co., Ltd.2 Haihe Biopharma Co., Ltd.2 Genentech, Inc.2 Meng Chao Hepatobiliary Hospital of Fujian Medical University2 Yongyi Zeng2 CARsgen Therapeutics Co., Ltd.2 Tianjin Medical University Cancer Institute and Hospital2 Shanghai Huilun Pharmaceutical Co., Ltd.2 Guangzhou Lupeng Pharmaceutical Company LTD.2 Seagen, a wholly owned subsidiary of Pfizer2 Hangzhou Gensciences Biopharmaceutical Co., Ltd.2 Beijing Tiantan Hospital2 Biotheus Inc.2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2 Guangdong Provincial People's Hospital2 Hangzhou Sumgen Biotech Co., Ltd.2 Qilu Pharmaceutical Co., Ltd.2 Xynomic Pharmaceuticals, Inc.2 Jing Tao2 Shanghai Chest Hospital2 Changping Laboratory2 Southeast University, China2 Wigen Biomedicine Technology (Shanghai) Co., Ltd.2 Candid Therapeutics2 Novo Nordisk A/S2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.2 Cascade Pharmaceuticals, Inc2 Ascentage Pharma Group Inc.2 Celgene2 Ensem Therapeutics1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 Zhiquan Hu1 zhangjie1 Fortvita Biologics (USA)Inc.1 Xcovery Holdings, Inc.1 Fuzhou Eye Hospital1 ForQaly Medical (Shanghai) Co., Ltd1 Epizyme, Inc.1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.1 Beijing Friendship Hospital1 Xiaomeng Zheng1 Pierre Fabre Medicament1 LaNova Medicines Limited1 Suzhou BlueHorse Therapeutics Co., Ltd.1 Shandong Provincial Hospital1 Incyte Corporation1 Sixth Affiliated Hospital, Sun Yat-sen University1 Beijing Pins Medical Co., Ltd1 Avistone Biotechnology Co., Ltd.1 Axter Therapeutics (Beijing) Co., Ltd1 Yong Lin, PhD1 Peking University People's Hospital1 Grit Biotechnology1 Shanghai Argo Biopharmaceutical Co., Ltd.1 ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.1 Teligene US1 Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.1 Exelixis1 Youzhi Zhu1 Acerand Therapeutics (Shanghai) Limited1 Zuoyi Jiao1 Shanghai Ming Ju Biotechnology Co., Ltd.1 Tasly Pharmaceutical Group Co., Ltd1 limeifang1 Lidian Chen1 Eikon Therapeutics1 Sichuan Jishengtang Pharmaceutical Co., Ltd.1 Xingshun Qi1 Junjie Xu1 Foresight Therapeutics (Hefei) Co., Ltd.1 Pulnovo Medical, Inc.1 Bio-Thera Solutions1 EMD Serono Research & Development Institute, Inc.1 Shenzhen Ionova Life Sciences Co., Ltd.1 Turning Point Therapeutics, Inc.1 Adagene Inc1 Shantou University Medical College1 Qiaojuan Guo1 Sichuan Enray Pharmaceutical Sciences Company1 Heronova Pharmaceuticals1 SineuGene Therapeutics Co., Ltd.1 Jacobio Pharmaceuticals Co., Ltd.1 Regeneron Pharmaceuticals1 Jia Fan1 Fujian University of Traditional Chinese Medicine1 Du Zhenggui1 Medtronic Cardiac Ablation Solutions1 Abivax S.A.1 Laekna Limited1 Fujian Maternity and Child Health Hospital1 Alnylam Pharmaceuticals1 The First Affiliated Hospital of Xiamen University1 Inventiva Pharma1 Eisai Inc.1 Transcenta Therapeutics (Hangzhou) Co., Ltd.1 Shenzhen Majory Biotechnology Co., Ltd.1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 Tianjin Medical University General Hospital1 Suzhou Puhe Pharmaceutical Technology Co., LTD1 Shanghai Pulmonary Hospital, Shanghai, China1 Xiamen University1 United Innomed(Shanghai) Limited1 Ningbo Newbay Technology Development Co., Ltd1 Wen-hong Zhang1 First People's Hospital of Hangzhou1 ChenXiaoChun1 Stryker Neurovascular1 Chongqing Peg-Bio Biopharm Co., Ltd.1 Sichuan Huiyu Pharmaceutical Co., Ltd1 Suzhou HepaThera Biotech Co., Ltd.1 Dizal (Jiangsu) Pharmaceutical Co., Ltd.1 Taizhou Hanzhong biomedical co. LTD1 ArriVent BioPharma, Inc.1 Acerand Therapeutics (Hong Kong) Limited1 Vividion Therapeutics, Inc.1 Ocumension Therapeutics (Suzhou) Co., Ltd1 Alpha Biopharma (Jiangsu) Co., Ltd.1 Advenchen Laboratories, LLC1 Peking Union Medical College Hospital1 Hangzhou DAC Biotechnology Co., Ltd.1 Southern Medical University, China1 GlaxoSmithKline1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Tongji Hospital1 Shanghai Mental Health Center1 Dermavon Holdings Limited1 InSilico Medicine Hong Kong Limited1 Chao Ji1 Astellas (Beijing) Pharmaceutical R&D Co., Ltd.1 Nanjing Medical University1 Evopoint Biosciences Inc.1 Changhai Hospital1 Ganzhou Hemay Pharmaceutical Co., Ltd1 Fuzhou First General Hospital Skin Disease Prevention and Control Hospital1 Genor Biopharma Co., Ltd.1 Guangdong Hengrui Pharmaceutical Co., Ltd1 Permed Biomedical Engineering Co., Ltd1 RJK Biopharma Ltd1 OncoC4, Inc.1 RenJi Hospital1 Huahui Health1 Lifetech Scientific (Shenzhen) Co., Ltd.1 Beijing Inno Medicine Co., Ltd.1 Beijing Continent Pharmaceutical Co, Ltd.1 First Affiliated Hospital of Guangxi Medical University1 Shanghai Allink Biotherapeutics Co., Ltd.1 Sir Run Run Shaw Hospital1 West China Hospital1 Chengdu New Radiomedicine Technology Co. LTD.1 Medtronic1 Yuanjiao Yan1 De-zhi Kang1 Ning Xu1 Beijing Anzhen Hospital1 Weibing Miao, PhD1 Suzhou Genhouse Bio Co., Ltd.1 Jazz Pharmaceuticals1 Linyu Xu1 TaiRx, Inc.1 Peking University Cancer Hospital & Institute1 Resonova (Shanghai) Medtech Limited1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Lyvgen Biopharma Holdings Limited1 Binhui Biopharmaceutical Co., Ltd.1 Nanjing First Hospital, Nanjing Medical University1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 Peking University1 Bo Wang,MD1 Shenzhen Core Medical Technology CO.,LTD.1 YiLin1 Fuzhou University Affiliated Provincial Hospital1 Chinese Academy of Medical Sciences1 Tong Chen, MD1 Harbin Medical University1 Johnson & Johnson Enterprise Innovation Inc.1 Sinotau Pharmaceutical Group1 The First Affiliated Hospital with Nanjing Medical University1 Jun Zhou1 Aragon Pharmaceuticals, Inc.1 Peijia Medical Technology (Suzhou) Co., Ltd.1 Ruijin Hospital1 BioDlink Biopharm Co., Ltd.1 Vor Biopharma1 Nuvation Bio Inc.1 The Second Affiliated Hospital of Fujian Medical University1 Xijing Hospital1 Zhejiang University1 Ming-Yuan Chen1 Guangdong Association of Clinical Trials1 Mirum Pharmaceuticals, Inc.1 Bivision Pharmaceuticals, Inc.1 Zhao Minghui1 Mundipharma (China) Pharmaceutical Co. Ltd1 Hangzhou Endonom Medtech Co., Ltd.1 Sun Yat-Sen University Cancer Center1 Mao-Lin Yan1 池畔1 Central South University1 Shanghai Institute Of Biological Products1 Suzhou Forlong Biotechnology Co., Ltd1 GeneSail Biotech (Shanghai) Co., Ltd.1 Clear sponsor filter
Target enrolment
to

Trials with a site in Fuzhou

6 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
NCT07217301IO Resistant Squamous and Nonsquamous NSCLC
Takeda
Phase 3
1,200
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Harbin, Xinxiang
2025-11-26
Recruiting
Takeda
Observational
200
Hefei, Beijing, Fuzhou, Hangzhou, Shantou, Shenzhen, Shijiazhuang, Harbin
2025-11-01
Active, closed
Takeda
Phase 3
2,099
Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Wuhan, Zhenjiang, Shanghai
2024-09-04
Recruiting
Takeda
Phase 3
408
Hefei, Wuhu, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Huizhou
2023-06-16
Active, closed
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
NCT03221036Moderately to Severely Active Ulcerative Colitis
Takeda
Phase 3
392
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Zhangzhou, Guangzhou, Meizhou
2017-08-03
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/fuzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Fuzhou that also match the filters currently applied.

How many clinical trials are recruiting in Fuzhou?

3 of the 6 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Fuzhou), 6 studies
PhaseStudiesRecruitingShare
Phase 34266.7%
Observational1116.7%
Phase 21016.7%

Most active sponsors

Lead sponsors with the most studies (Fuzhou)
Lead sponsorStudiesRecruiting
Takeda63
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.